New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Friday, Nov 20, 2026
Export LLY’s income statement to Excel — free account
Eli Lilly and Company
LLYHealthcare Drug Manufacturers General
Eli Lilly and Company’s revenue for fiscal 2025 (year ended December 2025) was $65.2 billion, up 44.7% from fiscal 2024.
- Revenue
- +38.6%
- EPS
- +16.3%
- Free cash flow
- +21.8%
- Total debt
- +15.0%
Quarter to September 2026, against a year earlier
1,351.35
0.30
−0.02%
Follow LLY
Alert me
Eli Lilly and Company 10-Q filed Apr 30, 2026
What changed
Part I, Item 2, Management’s Discussion and Analysis, against the 10-Q filed Oct 30, 2025: 13 added · 21 removed · 23 modified; 5 with only figures updated
-
Removed · Financial Results
NM - not meaningful